More on BIVI
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.63 |
|
|||
| Open | $1.63 | ||||
| 52 Wk High | $0.40 | ||||
| 52 Wk Low | $0.17 | ||||
| Day High | $1.63 | ||||
| Day Low | $1.63 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,410 | ||||
- Foremost Clean Energy and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
- Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2
- BioVie completes enrollment in long COVID treatment trial
- BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
- BioVie completes patient visits for Parkinson's drug trial
- BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease
- Form 10-Q BIOVIE INC. For: Mar 31
- BioVie to host virtual event on bezisterim Parkinson's treatment
- BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026
- RedChip's Biotech Investor Conference Replays Now Available
Entities mentioned with BIVI
- FDA | View Related Stories »
- Dividend | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- ThinkEquity | View Related Stories »
- S3 | View Related Stories »
- Show More...
